Molecular Templates to Present at the Oppenheimer 28th Annual Healthcare Conference
AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc., (Nasdaq:MTEM) a clinical stage biopharmaceutical company focused on the discovery and development of Engineered Toxin Bodies (ETBs), a new class of targeted biologic therapies that possess unique mechanisms of action in oncology, today announced that its management will provide a corporate overview at the Oppenheimer 28th Annual Healthcare Conference, taking place March 20-21 at the Westin New York Grand Central hotel in New York City.
 |  |  |
Presentation Details | Â | Â |
Date: | Â | Wednesday, March 21 |
Time: | Â | 10:20am Eastern Time |
Location: | Â | Track 3 |
 |  |  |
About Molecular Templates Â
Molecular Templates is focused on the discovery, development and commercialization of next-generation immunotoxins called Engineered Toxin Bodies (ETBs) for the treatment of cancers and other serious diseases. For additional information, please visit Molecular Templates’ website at www.mtem.com.
Investor Contact:
Andrew McDonald, Ph.D.
andrew@lifesciadvisors.com
646-597-6987
Adam Cutler
Chief Financial Officer
adam.cutler@mtem.com
862-204-4006
© 2018 GlobeNewswire, Inc. All Rights Reserved.